Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1954 1
1957 1
1958 1
1960 1
1964 1
1965 3
1966 4
1967 2
1968 5
1969 2
1970 5
1971 4
1972 1
1973 1
1974 1
1975 11
1976 3
1977 5
1978 7
1979 6
1980 1
1981 2
1983 1
1984 5
1985 3
1986 8
1987 3
1988 9
1989 13
1990 13
1991 9
1992 9
1993 19
1994 19
1995 22
1996 12
1997 30
1998 33
1999 45
2000 43
2001 45
2002 65
2003 50
2004 48
2005 70
2006 92
2007 90
2008 114
2009 116
2010 109
2011 123
2012 132
2013 175
2014 178
2015 198
2016 180
2017 199
2018 210
2019 202
2020 263
2021 320
2022 270
2023 278
2024 270
2025 267

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,955 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study.
Ferrante M, D'Haens G, Jairath V, Danese S, Chen M, Ghosh S, Hisamatsu T, Kierkus J, Siegmund B, Bragg SM, Crandall W, Durand F, Hon E, Lin Z, Lopes MU, Morris N, Protic M, Carlier H, Sands BE; VIVID Study Group. Ferrante M, et al. Among authors: lopes mu. Lancet. 2024 Dec 14;404(10470):2423-2436. doi: 10.1016/S0140-6736(24)01762-8. Epub 2024 Nov 21. Lancet. 2024. PMID: 39581202 Clinical Trial.
A proposed clinical classification for pituitary neoplasms to guide therapy and prognosis.
Ho KKY, Fleseriu M, Wass J, Katznelson L, Raverot G, Little AS, Castaño JP, Reincke M, Lopes MB, Kaiser UB, Chanson P, Gadelha M, Melmed S. Ho KKY, et al. Among authors: lopes mb. Lancet Diabetes Endocrinol. 2024 Mar;12(3):209-214. doi: 10.1016/S2213-8587(23)00382-0. Epub 2024 Jan 29. Lancet Diabetes Endocrinol. 2024. PMID: 38301678 Free PMC article. Review.
H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours.
Dibitetto D, Liptay M, Vivalda F, Dogan H, Gogola E, González Fernández M, Duarte A, Schmid JA, Decollogny M, Francica P, Przetocka S, Durant ST, Forment JV, Klebic I, Siffert M, de Bruijn R, Kousholt AN, Marti NA, Dettwiler M, Sørensen CS, Tille JC, Undurraga M, Labidi-Galy I, Lopes M, Sartori AA, Jonkers J, Rottenberg S. Dibitetto D, et al. Among authors: lopes m. Nat Commun. 2024 May 24;15(1):4430. doi: 10.1038/s41467-024-48715-1. Nat Commun. 2024. PMID: 38789420 Free PMC article.
Editorial: Non-pharmacological interventions for mental disorders.
de Pinho LG, Fonseca C, Gawęda Ł, Lopes M, Schneider BC. de Pinho LG, et al. Among authors: lopes m. Front Psychol. 2024 Mar 22;15:1363348. doi: 10.3389/fpsyg.2024.1363348. eCollection 2024. Front Psychol. 2024. PMID: 38586291 Free PMC article. No abstract available.
Change in Urine Albumin-Creatinine Ratio and Occurrence of Hyperkalemia in Patients Initiating Finerenone in the USA: A Cohort Study from the FOUNTAIN Platform.
Kovesdy CP, Ebert N, Vizcaya D, Walsh M, Kosiborod MN, Layton JB, Ziemiecki R, Johannes CB, Pladevall-Vila M, Gee PO, Jefferson N, Chicoye A, Lopes M, Thapa BB, Curhan G, Rangel L, Bhartia M, Liu F, Farjat AE, Oberprieler NG. Kovesdy CP, et al. Among authors: lopes m. Nephron. 2025;149(7):371-383. doi: 10.1159/000543923. Epub 2025 Feb 27. Nephron. 2025. PMID: 40015260 Free PMC article.
3,955 results